Estrogen receptor-positive (ER+) and lymph node-negative (LN−) is a common subtype of invasive breast cancer (IBC)3,4, for which the standard treatment includes the breast-conserving surgery followed by radiation and adjuvant hormonal therapy. Here, ESR1 is linked to invasive breast carcinoma.